KANG Ikang Healthcare Grp. ADS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2016.

Commission File Number:  001-36403

IKANG HEALTHCARE GROUP, INC.

(Exact name of registrant as specified in its charter)

B-6F, Shimao Tower
92A Jianguo Road
Chaoyang District, Beijing 100022

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x   Form 40-F  o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T  Rule 101(b)(7): o

IKANG HEALTHCARE GROUP, INC.

Form 6-K

CONTENTS

On November 28, 2016, iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Islands (the “ Company ”), entered into an amendment (“ Amendment No. 1 ”) to the Rights Agreement, dated as of December 2, 2015 (the “ Rights Agreement ”), between the Company and American Stock Transfer & Trust Company, L.L.C., as Rights Agent (the “ Rights Agent ”), to extend the expiration date of the Rights Agreement and the rights contained therein for one year to December 2, 2017.

The foregoing summary of Amendment No. 1 does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 1, a copy of which is filed as Exhibit 4.1 to this Form 6-K and is incorporated herein by reference.

A copy of the Rights Agreement and a summary of its material terms were filed as Exhibit 4.1 to Company’s Current Report on Form 6-K, filed with the SEC on December 3, 2015, and are incorporated herein by reference by Exhibit 4.2 .